{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:23:04Z","timestamp":1788441784266,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["08C607_2006"],"award-info":[{"award-number":["08C607_2006"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41431-020-0658-0","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T11:05:52Z","timestamp":1591614352000},"page":"1432-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Digenic inheritance of subclinical variants in Noonan Syndrome patients: an alternative pathogenic model?"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2170","authenticated-orcid":false,"given":"Luca","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-0482","authenticated-orcid":false,"given":"Maria Teresa","family":"Bonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Monterosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8099-4348","authenticated-orcid":false,"given":"Federica","family":"Chiappori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Gelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6481-8467","authenticated-orcid":false,"given":"Paola","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"658_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ajmg.a.37736","volume":"170","author":"JE Allanson","year":"2016","unstructured":"Allanson JE. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras\/MAPK signaling pathway. Am J Med Genet Part A. 2016;170:2570\u20137.","journal-title":"Am J Med Genet Part A"},{"key":"658_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","volume":"126","author":"AA Romano","year":"2010","unstructured":"Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines. Pediatrics. 2010;126:746\u201359.","journal-title":"Pediatrics."},{"issue":"Jan","key":"658_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-2-4","volume":"2","author":"I van der Burgt","year":"2007","unstructured":"van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007;2:4.","journal-title":"Orphanet J Rare Dis."},{"key":"658_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11689-018-9239-8","volume":"10","author":"EI Pierpont","year":"2018","unstructured":"Pierpont EI, Hudock RL, Foy AM, Semrud-Clikeman M, Pierpont ME, Berry SA, et al. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord. 2018;10:21. https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-018-9239-8.","journal-title":"J Neurodev Disord."},{"key":"658_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61:33\u20139.","journal-title":"J Hum Genet."},{"key":"658_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.21492","volume":"32","author":"F Lepri","year":"2011","unstructured":"Lepri F, De Luca A, Stella L, Rossi C, Baldassarre G, Pantaleoni F, et al. SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat. 2011;32:760\u201372. https:\/\/doi.org\/10.1002\/humu.21492.","journal-title":"Hum Mutat."},{"key":"658_CR7","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/ajmg.a.33564","volume":"152A","author":"M Longoni","year":"2010","unstructured":"Longoni M, Moncini S, Cisternino M, Morella IM, Ferraiuolo S, Russo S, et al. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations. Am J Med Genet A. 2010;152A:2176\u201384. https:\/\/doi.org\/10.1002\/ajmg.a.33564.","journal-title":"Am J Med Genet A."},{"key":"658_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00439-018-1951-7","volume":"138","author":"I Umeki","year":"2019","unstructured":"Umeki I, Niihori T, Abe T, Kanno ichiro S, Okamoto N, Mizuno S, et al. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1\u2013PPP1CB complexes. Hum Genet. 2019;138:21\u201335. https:\/\/doi.org\/10.1007\/s00439-018-1951-7.","journal-title":"Hum Genet"},{"key":"658_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/ccr3.1568","volume":"6","author":"A Tamura","year":"2018","unstructured":"Tamura A, Uemura S, Matsubara K, Kozuki E, Tanaka T, Nino N, et al. Co-occurrence of hypertrophic cardiomyopathy and juvenile myelomonocytic leukemia in a neonate with Noonan syndrome, leading to premature death. Clin case reports. 2018;6:1202\u20137. https:\/\/doi.org\/10.1002\/ccr3.1568.","journal-title":"Clin case reports"},{"key":"658_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ejhg.2014.115","volume":"23","author":"LELM Vissers","year":"2015","unstructured":"Vissers LELM, Bonetti M, Paardekooper Overman J, Nillesen WM, Frints SGM, de Ligt J, et al. Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome. Eur J Hum Genet. 2015;23:317\u201324.","journal-title":"Eur J Hum Genet"},{"key":"658_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20894-0","volume":"8","author":"GKC Leung","year":"2018","unstructured":"Leung GKC, Luk HM, Tang VHM, Gao WW, Mak CCY, Yu MHC, et al. Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. Sci Rep. 2018;8:2421.","journal-title":"Sci Rep."},{"key":"658_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1755-8166-7-28","volume":"7","author":"J-L Chen","year":"2014","unstructured":"Chen J-L, Zhu X, Zhao T-L, Wang J, Yang Y-F, Tan Z-P. Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11. Mol Cytogenet. 2014;7:28. http:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/1755-8166-7-28.","journal-title":"Mol Cytogenet."},{"key":"658_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","volume":"20","author":"JJ Johnston","year":"2018","unstructured":"Johnston JJ, van der Smagt JJ, Rosenfeld JA, Pagnamenta AT, Alswaid A, Baker EH, et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet Med. 2018;20:1175\u201385. http:\/\/www.nature.com\/articles\/gim2017249.","journal-title":"Genet Med."},{"key":"658_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13023-016-0479-y","volume":"11","author":"B Gilbert-Dussardier","year":"2016","unstructured":"Gilbert-Dussardier B, Briand-Suleau A, Laurendeau I, Bilan F, Cav\u00e9 H, Verloes A, et al. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities. Orphanet J Rare Dis. 2016;11:101. http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0479-y.","journal-title":"Orphanet J Rare Dis."},{"key":"658_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet (London, England). 2013;381:333\u201342. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067361261023X.","journal-title":"Lancet (London, England)."},{"key":"658_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejmg.2017.11.007","volume":"61","author":"MP Recalcati","year":"2018","unstructured":"Recalcati MP, Bonati MT, Beltrami N, Cardarelli L, Catusi I, Costa A, et al. Molecular cytogenetics characterization of seven small supernumerary marker chromosomes derived from chromosome 19: Genotype-phenotype correlation and review of the literature. Eur J Med Genet. 2018;61:173\u201380.","journal-title":"Eur J Med Genet"},{"key":"658_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2009.09.003","volume":"85","author":"S Kohler","year":"2009","unstructured":"Kohler S, Schulz MH, Krawitz P, Bauer S, Dolken S, Ott CE, et al. Clinical diagnostics in human genetics with semantic similarity searches in ontologies. Am J Hum Genet. 2009;85:457\u201364.","journal-title":"Am J Hum Genet"},{"key":"658_CR18","doi-asserted-by":"publisher","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","volume":"45","author":"S Kohler","year":"2017","unstructured":"Kohler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Ayme S, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45:D865\u201376.","journal-title":"Nucleic Acids Res"},{"key":"658_CR19","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M508017200","volume":"281","author":"M-F Galliano","year":"2006","unstructured":"Galliano M-F, Toulza E, Gallinaro H, Jonca N, Ishida-Yamamoto A, Serre G, et al. A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis. J Biol Chem. 2006;281:5780\u20139. http:\/\/www.jbc.org\/lookup\/doi\/10.1074\/jbc.M508017200.","journal-title":"J Biol Chem."},{"key":"658_CR20","doi-asserted-by":"publisher","first-page":"21017","DOI":"10.1074\/jbc.M000507200","volume":"275","author":"OM Andersen","year":"2000","unstructured":"Andersen OM, Christensen LL, Christensen PA, S\u00f8rensen ES, Jacobsen C, Moestrup SK, et al. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP. J Biol Chem. 2000;275:21017\u201324. http:\/\/www.jbc.org\/lookup\/doi\/10.1074\/jbc.M000507200.","journal-title":"J Biol Chem."},{"key":"658_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19467855.","journal-title":"Curr Opin Genet Dev."},{"key":"658_CR22","doi-asserted-by":"crossref","unstructured":"Chinton J, Huckstadt V, Mucciolo M, Lepri F, Novelli A, Gravina LP, et al. Providing more evidence on LZTR1 variants in Noonan syndrome patients. Am J Med Genet Part A. 2019.","DOI":"10.1002\/ajmg.a.61445"},{"key":"658_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","volume":"52","author":"GL Yamamoto","year":"2015","unstructured":"Yamamoto GL, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, et al. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet. 2015;52:413\u201321. http:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2015-103018.","journal-title":"J Med Genet."},{"key":"658_CR24","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/humu.22682","volume":"35","author":"K Brand","year":"2014","unstructured":"Brand K, Kentsch H, Glashoff C, Rosenberger G. RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR. Hum Mutat. 2014;35:1372\u201381. https:\/\/doi.org\/10.1002\/humu.22682.","journal-title":"Hum Mutat."},{"key":"658_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2350-15-14","volume":"15","author":"FR Lepri","year":"2014","unstructured":"Lepri FR, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, et al. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Med Genet. 2014;15:14. http:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-15-14.","journal-title":"BMC Med Genet"},{"issue":"May","key":"658_CR26","doi-asserted-by":"publisher","first-page":"18504","DOI":"10.1074\/jbc.M410265200","volume":"280","author":"Y Takayama","year":"2005","unstructured":"Takayama Y, May P, Anderson RGW, Herz J. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). J Biol Chem. 2005;280:18504\u201310. http:\/\/www.jbc.org\/lookup\/doi\/10.1074\/jbc.M410265200.","journal-title":"J Biol Chem."},{"key":"658_CR27","doi-asserted-by":"publisher","first-page":"ra18","DOI":"10.1126\/scisignal.2000188","volume":"2","author":"Y Shi","year":"2009","unstructured":"Shi Y, Mantuano E, Inoue G, Campana WM, Gonias SL. Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci Signal. 2009;2:ra18. http:\/\/stke.sciencemag.org\/cgi\/doi\/10.1126\/scisignal.2000188.","journal-title":"Sci Signal."},{"key":"658_CR28","doi-asserted-by":"publisher","first-page":"e2729","DOI":"10.1371\/journal.pone.0002729","volume":"3","author":"M-F Galliano","year":"2008","unstructured":"Galliano M-F, Toulza E, Jonca N, Gonias SL, Serre G, Guerrin M. Binding of alpha2ML1 to the low density lipoprotein receptor-related protein 1 (LRP1) reveals a new role for LRP1 in the human epidermis. Sommer P, editor. PLoS ONE. 2008;3:e2729. https:\/\/doi.org\/10.1371\/journal.pone.0002729.","journal-title":"PLoS ONE."},{"key":"658_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12967-017-1342-1","volume":"15","author":"J Tang","year":"2017","unstructured":"Tang J, Liao Y, He S, Shi J, Peng L, Xu X, et al. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK\/JNK-ATF2-cyclinD1 signaling. J Transl Med. 2017;15:238. https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1342-1.","journal-title":"J Transl Med."},{"key":"658_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature."},{"key":"658_CR31","doi-asserted-by":"publisher","first-page":"e0119898","DOI":"10.1371\/journal.pone.0119898","volume":"10","author":"R Muro","year":"2015","unstructured":"Muro R, Nitta T, Okada T, Ideta H, Tsubata T, Suzuki H. The Ras GTPase-activating protein Rasal3 supports survival of naive T cells. Akiyama T, editor. PLoS ONE. 2015;10:e0119898. https:\/\/doi.org\/10.1371\/journal.pone.0119898.","journal-title":"PLoS ONE."},{"key":"658_CR32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/eji.201444977","volume":"45","author":"S Saito","year":"2015","unstructured":"Saito S, Kawamura T, Higuchi M, Kobayashi T, Yoshita-Takahashi M, Yamazaki M, et al. RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells. Eur J Immunol. 2015;45:1512\u201323. https:\/\/doi.org\/10.1002\/eji.201444977.","journal-title":"Eur J Immunol."},{"key":"658_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10048-019-00581-6","volume":"20","author":"MT Bonati","year":"2019","unstructured":"Bonati MT, Castronovo C, Sironi A, Zimbalatti D, Bestetti I, Crippa M, et al. 9q34.3 microduplications lead to neurodevelopmental disorders through EHMT1 overexpression. Neurogenetics. 2019;20:145\u201354.","journal-title":"Neurogenetics."},{"key":"658_CR34","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ajmg.a.35363","volume":"158A","author":"JA Fahrner","year":"2012","unstructured":"Fahrner JA, Frazier A, Bachir S, Walsh MF, Applegate CD, Thompson R, et al. A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1. Am J Med Genet A. 2012;158A:1414\u201321. https:\/\/doi.org\/10.1002\/ajmg.a.35363.","journal-title":"Am J Med Genet A"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0658-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:02Z","timestamp":1684616522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0658-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-0658-0","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}